Clinical Trials Sponsored by Ocular Therapeutix

Total 6389 results

Prim. Prof. Dr. Oliver Findl, MBA

Recruiting

Rotation Stability of Toric Intraocularlens (IOL) Compared Sitting Against Lying After Cataract Operation

Astigmatism

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Withdrawn

Performance of a Hydrophilic and a Hydrophobic Intraocular Lens of Similar Design

Cataract

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Completed

Diurnal Changes of the Cornea - a Pilot Study

Astigmatism

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

Perioperative Stress and Pain Perception of Second Eye Cataract Surgery

Cataract

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Completed

Protecting the Corneal Endothelium During Cataract Surgery Using the Anterior Capsule

Endothelial Cell Loss, Corneal
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

Prediction of Pseudophakodonesis of Intraocular Lenses

Cataract

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Completed

Morphologic Changes After Membrane Peeling With Air Tamponade and Balanced Salt Solution

Epiretinal Membrane | Macular Pucker

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Completed

Intraocular Lens Power Calculation Using Pre- and Intra-operative Measurements

Cataract

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

A Study of the Beneficial Effects of Eplerenone on Central Serous Chorioretinopathy

Central Serous Chorioretinopathy

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Completed

Intra-operative Measurements to Predict the Position of the Intraocular Lens Post-operatively

Cataracts
Prim. Prof. Dr. Oliver Findl, MBA

Recruiting

Intense Pulsed Light in Meibomian Gland Dysfunction

Meibomian Gland Dysfunction

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Completed

Repeatability in Measurements of Two ssOCT and One OLCR Biometer

Cataract Senile

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

LEC Proliferation in Vivo and In-vitro

Posterior Capsule Opacification

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

Computer-based Tutorial for the Informed Consent Process for Cataract Surgery in Turkish or Serbian Speaking Patients

Cataract

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

Comparison of a New EDOF-IOL With a Standard-EDOF-IOL

Cataract

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

Reading Quality in Three Different Patient Groups

Pseudophakia

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

Comparison of Stellaris Standard Infusion With Stellaris Elite

Cataract

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

Comparing an Intraoperative vs. a Standard Wavefront Device

Cataract

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

High Resolution Immersion Ultrasound for iIOL Power Calculation

Cataract

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Completed

Impact of a Corneal Pre-cut on Wound Architecture and Astigmatism in Cataract Surgery - a Pilot Study

Cataract

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Recruiting

Computer-based Tutorial and Automated Speech Recognition for Intravitreal Drug Injections

Age-related Macular Degeneration | Diabetic Macular Edema | Retinal Vein Occlusion

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

Comparison of Wide-field Retinal Imaging

Retinal Disease

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

Posterior Capsule Opacification After Lens Capsule Polishing

Posterior Capsule Opacification

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

Assessing the Astigmatism Reducing Effect With Toric IOLs in Eyeswith Low Astigmatism (Low Asti)

Cataract | Astigmatism

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

Anterior Chamber Depth Variability Between Two Lenses With Different Materials

Cataract

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

Reading Analysis in Ophthalmologic Patients

Glaucoma | Age Related Macular Degeneration | Epiretinal Membrane | Diabetic Maculopathy

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

Comparison of 2 Diffractive Trifocal IOLs

Cataract

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

Low-add Multifocal vs. Monofocal IOLs

Cataract

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Completed

Performance of a Single-piece Toric Acrylic Intraocular Lens

Cataract | Corneal Astigmatism
Prim. Prof. Dr. Oliver Findl, MBA
ESCRS

Unknown

Influence of Posterior Vitreous Detachment on Retinal Detachment After Lens Surgery in Myopic Eyes (MYOPRED)

Cataract | Myopia | Pseudophakic Retinal Detachment

Austria
Therapeutic Concepts

Completed

Study of the 48-Week Virologic and Immunologic Response to Lopinavir/Ritonavir (Kaletra) in HIV Positive Adult Patients

HIV Infections

United States
Therapeutic Concepts

Completed

Nucleoside Switch Pilot for Virologically Controlled HIV Subjects With Decreasing CD4 Cells Who Have Received TDF-based ARV Therapy (EPZSwitch)

HiV1- Positive

United States
Akebia Therapeutics
Cyclerion Therapeutics

Completed

A Study to Evaluate the Soluble Guanylate Cyclase (sGC) Stimulator IW-1973 in Diabetic Nephropathy / Diabetic Kidney Disease as Measured by Albuminuria

Type 2 Diabetes Mellitus With Diabetic Nephropathy

United States
Akebia Therapeutics
Cyclerion Therapeutics

Completed

A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF) (CAPACITY-HFpEF)

Heart Failure With Preserved Ejection Fraction

United States, Canada
Universidad Popular Autónoma del Estado de Puebla

Completed

Alpha Lipoic Acid for Treatment of Diabetic Neuropathy

Diabetic Neuropathy
Universidad Popular Autónoma del Estado de Puebla

Completed

Exercise on Expression of Heat Shock Protein 70 in Arterial Risk (HSP70)

Peripheral Arterial Disease

Mexico
CRISPR Therapeutics AG

Recruiting

A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors

Clear Cell Renal Cell Carcinoma | Pancreatic Adenocarcinoma | Cervical Carcinoma | Malignant Pleural Mesothelioma | Esophageal Carcinoma

United States
CRISPR Therapeutics AG

Active, not recruiting

A Safety and Efficacy Study Evaluating CTX130 in Subjects With Relapsed or Refractory T or B Cell Malignancies (COBALT-LYM)

T Cell Lymphoma

United States, Australia, Canada
CRISPR Therapeutics AG

Active, not recruiting

A Safety and Efficacy Study Evaluating CTX110 in Subjects With Relapsed or Refractory B-Cell Malignancies (CARBON)

B-cell Lymphoma | Non-Hodgkin Lymphoma | B-cell Malignancy | Adult B Cell ALL

United States, Spain, Canada, France, Germany, Australia
Bacainn Therapeutics, Inc.

Completed

A Phase 1, Single-Ascending-Dose Study of BT051 in Healthy Subjects

Healthy Volunteers

United States
Celsus Therapeutics PLC

Terminated

Double-Blind, Trial to Evaluate the Safety and Efficacy of MRX-6 Cream 2% (C012013)

Atopic Dermatitis

Israel
Eikon Therapeutics
Impact Therapeutics, Inc.

Recruiting

A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors

Advanced Solid Tumor

Australia, United States
APRINOIA Therapeutics, LLC

Active, not recruiting

A First-in-Human Study to Assess Single Doses of APNmAb005 in Healthy Participants

Alzheimer Disease | Tauopathies | Healthy Volunteers

United States
CRISPR Therapeutics AG

Active, not recruiting

A Safety and Efficacy Study Evaluating CTX130 in Subjects With Relapsed or Refractory Renal Cell Carcinoma (COBALT-RCC)

Renal Cell Carcinoma

United States, Australia, Canada, Netherlands
CRISPR Therapeutics AG

Recruiting

A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies

Follicular Lymphoma | B-cell Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Non-Hodgkin Lymphoma | B-cell Malignancy | Large B-cell Lymphoma | Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

United States
CRISPR Therapeutics AG

Enrolling by invitation

A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies

Hematologic Malignancy | Solid Malignancy

United States
CRISPR Therapeutics AG

Active, not recruiting

A Safety and Efficacy Study Evaluating CTX120 in Subjects With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

United States, Spain, Australia, Canada
APRINOIA Therapeutics, LLC

Active, not recruiting

Evaluation of [18F]APN-1607 PET Uptake in Alzheimer's Disease Patients Compared With Healthy Subjects

Healthy Volunteers | Alzheimer's Disease | Mild Cognitive Impairment Due to Alzheimer's Disease

United States
University of Florida
Ocala Royal Dames

Active, not recruiting

Study of Cardiac MRI in Patients With Left-Sided Breast Cancer Receiving Radiation Therapy

Breast Cancer

United States
Morphic Therapeutic, Inc

Active, not recruiting

A Phase 2a Open-Label Study to Evaluate the Efficacy and Safety of MORF-057 in Adults With UC

Inflammatory Bowel Diseases | Colitis, Ulcerative

United States, Poland

Clinical Trials Sponsored by Ocular Therapeutix

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Djibouti

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations